You may be eligible to take part in the Novaremed study, a clinical trial to test the safety and effectiveness of a new drug for treating pain from Diabetic Peripheral Neuropathy (DPN).
Find a Location
Please view study site locations and local contact information below. To learn more, click on your local site to complete our eligibility survey. If the survey shows you may qualify, you can provide contact information for the local study team who will reach out to you with more information. Your contact information will be kept confidential and will not be shared with any third parties without your permission unless required by law.
710 West 168th Street
New York, New York 10032
1 Gustave L. Levy Place
New York, New York 10029
101 Merrimac Street
Boston, Massachusetts 02114
211 East Ontario Street
Chicago, Illinois 60611
21 North Park Street
Madison, Wisconsin 53715
9452 Medical Center Drive
San Diego, California 92037
1600 Southwest Archer Road
Gainesville, Florida 32610
5750 Centre Avenue
Pittsburgh, Pennsylvania 15206
2180 South Clinton Avenue
Rochester, New York 14618
175 Medical Drive North
Salt Lake City, Utah 84132
1959 Northeast Pacific Street
Seattle, Washington 98195
11958 West Broad Street
Henrico, Virginia 23233
A clinical trial is a research study to test a new medical treatment in people. The objective is to learn if a new treatment is safe and effective. New treatments can be a new drug, diet, device (e.g. pacemaker), advice, or other therapy. Sometimes, a new treatment is compared to those that already exist.
This study drug, “NRD135S.E1,” resembles a tea used to treat pain in a Siberian village.
You will make up to 7 in person and 2 virtual visits during the approximately 25-week study. You will be expected to take the study drug once each day and report your pain and medicine use on a smartphone or iPad once daily. We will lend you a device if you don’t have one. You will wear an actigraphy watch during parts of the study.
Yes, you would receive compensation for your time and effort attending study visits.
If you complete the eligibility survey, your information will only be shared with members of the local study team. We do not share your information with any other third party without your permission except as required by law.
You may be eligible if you:
o Are at least 18 years of age
o Are diagnosed with diabetes
o Have moderate or severe pain from DPN
o If you are a female of child-bearing potential (who can have children) you are willing to use 2 kinds of birth control during the study.
Choose a study site near you using the map tool. You will find contact information and a screening survey.
The Early Phase Pain Investigation Clinical Network (EPPIC-Net) is funded by the Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®. EPPIC-Net studies how to improve treatment of acute and chronic pain. This clinical trial has the potential to improve the lives of people living with pain due to DPN.
Learn MorePlease use the map to find your institutions’ pre-screening survey to see if you meet the eligibility requirements. You can also find information to contact site staff directly.